HC Deb 29 March 2004 vol 419 cc1219-20W
Paul Flynn

To ask the Secretary of State for Health how he plans to ensure consumer representation on the Medicines and Healthcare Products Regulatory Agency's expert working group on selective serotonin reuptake inhibitors. [162492]

Ms Rosie Winterton

The Committee on the Safety of Medicine's expert working group on the safety of selective serotonin reuptake inhibitors included lay membership from its inception—uniquely for an expert group. Following the resignation of one of the lay members, we intend to appoint another lay member to the group as soon as possible.